As one of world’s largest CROs, PAREXEL is right where you need us with the global experience, infrastructure, knowledge, and technology to conduct pivotal clinical research trials of any size. Whatever the size of your study, we can plan and manage your pivotal trials from beginning to end, including: clinical trial design, protocol development, site and patient recruitment, clinical monitoring, database design, document management, clinical logistics, and medical writing. PAREXEL works closely with investigators, patients, and sites to ensure that all protocols are followed and all deadlines are met – reducing the costs, risks, and delays of conducting your trials.
Because pivotal clinical research trials are increasing in size and complexity, successful implementation of these studies requires rapid site identification and study start-up, effective patient recruitment, and reliable achievement of study timelines and milestones. PAREXEL’s global presence has been specifically designed to provide clients with in-depth regulatory expertise, extensive knowledge of premier investigators, and synchronized communication systems. Our Phase IIb/III resources span the Americas, Europe, Africa, and Asia, helping our partners access global markets and diverse patient populations, while lowering the cost of conducting clinical research. The expert teams in PAREXEL’s local offices also understand the different medical, cultural, and regulatory requirements that must be accommodated to facilitate timely, cost-efficient trials.
Equally important, we tailor our services to fit your strategic goals and the specific requirements of your company and your products, so we are right where you need us to reduce the costs, risks, and delays of conducting pivotal clinical trials.
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.